東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Photophysical and Biological Investi...

Marker, Sierra Cozette.

FindBook

Google Book

Amazon

博客來

Photophysical and Biological Investigations of Rhenium-Based Anticancer Agents.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Photophysical and Biological Investigations of Rhenium-Based Anticancer Agents./
作者:	Marker, Sierra Cozette.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
面頁冊數:	653 p.
附註:	Source: Dissertations Abstracts International, Volume: 81-12, Section: B.
Contained By:	Dissertations Abstracts International81-12B.
標題:	Inorganic chemistry. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27963573
ISBN:	9798641035932

Photophysical and Biological Investigations of Rhenium-Based Anticancer Agents.
Marker, Sierra Cozette.

Photophysical and Biological Investigations of Rhenium-Based Anticancer Agents. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 653 p.

Source: Dissertations Abstracts International, Volume: 81-12, Section: B.

Thesis (Ph.D.)--Cornell University, 2020.

This item must not be sold to any third party vendors.

Despite significant advances over the last fifty years, cancer remains one of the leading causes of death worldwide. Among the most effective and well-studied class of chemotherapeutic agents are the FDA- approved platinum-based drugs cisplatin, carboplatin, and oxaliplatin. Given the clinical success of the platinum-based compounds, extensive research efforts have been directed towards investigating the anticancer activity of complexes of alternative metal ions, with the hopes that these inorganic complexes can overcome some of the challenges with current chemotherapy regimens. In Chapter 1 we summarize recent investigations of anticancer agents comprising the elements, rhenium, osmium, and iridium. We then explore a subset of rhenium(I) tricarbonyl complexes bearing varying axial ligands for their anticancer cancer and photoluminescent imaging properties (Chapter 2). After which, we focus our attention on mainly rhenium(I) tricarbonyl complexes that utilize light as a mechanism for cancer cell targeting (Chapter 3). A novel tricarbonyl rhenium isonitrile polypyridyl (TRIP) complex was investigated and found to have potent anticancer activity in a variety of cancer cell lines and exhibit a distinct mechanism of cell death from that of platinum-based drugs, specifically endoplasmic reticulum stress due to accumulation of misfolded proteins (Chapter 4). Due to the interesting mechanism of cell death of the TRIP complex, we explored the in vivo activity of TRIP other derivatives of TRIP and determined that they have the same biological phenotype as the parent complex, as well high anticancer activity that is dictated by the donor strength of the equatorial polypyridyl ligand (Chapter 5). A TRIP-resistant ovarian cancer cell was developed and its resistance phenotype was thoroughly investigated and its resistance was found to be a consequence of overexpression of the efflux transporter P-glycoprotein and the metal detoxifying protein metallothionine (Chapter 6). Lastly, novel rhenium(I) tricarbonyl complexes bearing organelle- targeting ligands were explored for their ability to produce toxic singlet oxygen as photodynamic therapeutic agents (Chapter 7). In the final chapter, we switch focuses and we highlight outreach activities for middle and high school students that helps teach students about radioactivity (Chapter 8). In appendix A, we show the biological activity of platinum complexes bearing azobenzene ligands.

ISBN: 9798641035932Subjects--Topical Terms:

3173556
Inorganic chemistry.
Subjects--Index Terms:

Cancer

Photophysical and Biological Investigations of Rhenium-Based Anticancer Agents.
LDR:03522nmm a2200337 4500 001 2273188
005 20201105110403.5
008 220629s2020 ||||||||||||||||| ||eng d
020 $a 9798641035932
035 $a (MiAaPQ)AAI27963573
035 $a AAI27963573
040 $a MiAaPQ $c MiAaPQ
100 1 $a Marker, Sierra Cozette. $3 3550616
245 1 0 $a Photophysical and Biological Investigations of Rhenium-Based Anticancer Agents.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 653 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-12, Section: B.
500 $a Advisor: Wilson, Justin.
502 $a Thesis (Ph.D.)--Cornell University, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a Despite significant advances over the last fifty years, cancer remains one of the leading causes of death worldwide. Among the most effective and well-studied class of chemotherapeutic agents are the FDA- approved platinum-based drugs cisplatin, carboplatin, and oxaliplatin. Given the clinical success of the platinum-based compounds, extensive research efforts have been directed towards investigating the anticancer activity of complexes of alternative metal ions, with the hopes that these inorganic complexes can overcome some of the challenges with current chemotherapy regimens. In Chapter 1 we summarize recent investigations of anticancer agents comprising the elements, rhenium, osmium, and iridium. We then explore a subset of rhenium(I) tricarbonyl complexes bearing varying axial ligands for their anticancer cancer and photoluminescent imaging properties (Chapter 2). After which, we focus our attention on mainly rhenium(I) tricarbonyl complexes that utilize light as a mechanism for cancer cell targeting (Chapter 3). A novel tricarbonyl rhenium isonitrile polypyridyl (TRIP) complex was investigated and found to have potent anticancer activity in a variety of cancer cell lines and exhibit a distinct mechanism of cell death from that of platinum-based drugs, specifically endoplasmic reticulum stress due to accumulation of misfolded proteins (Chapter 4). Due to the interesting mechanism of cell death of the TRIP complex, we explored the in vivo activity of TRIP other derivatives of TRIP and determined that they have the same biological phenotype as the parent complex, as well high anticancer activity that is dictated by the donor strength of the equatorial polypyridyl ligand (Chapter 5). A TRIP-resistant ovarian cancer cell was developed and its resistance phenotype was thoroughly investigated and its resistance was found to be a consequence of overexpression of the efflux transporter P-glycoprotein and the metal detoxifying protein metallothionine (Chapter 6). Lastly, novel rhenium(I) tricarbonyl complexes bearing organelle- targeting ligands were explored for their ability to produce toxic singlet oxygen as photodynamic therapeutic agents (Chapter 7). In the final chapter, we switch focuses and we highlight outreach activities for middle and high school students that helps teach students about radioactivity (Chapter 8). In appendix A, we show the biological activity of platinum complexes bearing azobenzene ligands.
590 $a School code: 0058.
650 4 $a Inorganic chemistry. $3 3173556
650 4 $a Cellular biology. $3 3172791
653 $a Cancer
653 $a Oxaliplatin
653 $a Platinum-based drugs
690 $a 0488
690 $a 0379
710 2 $a Cornell University. $b Chemistry and Chemical Biology. $3 3281129
773 0 $t Dissertations Abstracts International $g 81-12B.
790 $a 0058
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27963573